JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liao, L.
Right arrow Articles by Borges-Neto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liao, L.
Right arrow Articles by Borges-Neto, S.
Journal of Nuclear Medicine Vol. 46 No. 1 5-11
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Prediction of Death and Nonfatal Myocardial Infarction in High-Risk Patients: A Comparison Between the Duke Treadmill Score, Peak Exercise Radionuclide Angiography, and SPECT Perfusion Imaging

Lawrence Liao, MD1, William T. Smith, IV, MD1, Robert H. Tuttle, MS1, Linda K. Shaw, MS1, R. Edward Coleman, MD2 and Salvador Borges-Neto, MD2

1 Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, North Carolina
2 Nuclear Medicine Division, Department of Radiology, Duke University Medical Center, Durham, North Carolina

Radionuclide exercise testing provides prognostic information in patients with known or suspected coronary artery disease (CAD). The relative contribution of 3 noninvasive tests—the Duke treadmill score (DTS), first-pass radionuclide angiography with calculation of the ejection fraction (RNA-EF), and perfusion SPECT—has not been comparatively assessed in a high-risk population undergoing all 3 tests. Methods: We identified 997 patients (75% male; median age, 60 y) who underwent exercise treadmill testing with RNA-EF and SPECT perfusion imaging as a single test. The relative prognostic power of each test was evaluated in both an unadjusted manner and after adjustment for differences in baseline characteristics using Cox proportional hazards models. Results: During a median follow-up of 4.1 y, 175 patients experienced outcome events. Without adjustment for baseline patient characteristics, each of the modalities proved highly predictive of the composite endpoint of cardiovascular death or nonfatal myocardial infarction (MI) (DTS {chi}2 = 18.9, P = 0.0001; RNA-EF {chi}2 = 34, P = 0.0001; SPECT {chi}2 = 11.5, P = 0.0007). In clinically risk-adjusted models, RNA-EF was the most powerful predictor of cardiovascular death compared with the DTS and SPECT ({chi}2 = 40.5, 27.6, and 19.8, respectively). Conversely, exercise SPECT perfusion was a stronger predictor of nonfatal MI than the DTS or RNA-EF ({chi}2 = 26.7, 15.7, and 16.7, respectively). Conclusion: The DTS, perfusion SPECT, and RNA-EF are each significant predictors of cardiovascular events in high-risk patients. The optimal risk stratification of patients for CAD may include all 3 modalities.

Key Words: coronary disease • prognosis • nuclear medicine


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. D. Metz, M. Beattie, R. Hom, R. F. Redberg, D. Grady, and K. E. Fleischmann
The Prognostic Value of Normal Exercise Myocardial Perfusion Imaging and Exercise Echocardiography: A Meta-Analysis
J. Am. Coll. Cardiol., January 16, 2007; 49(2): 227 - 237.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons and P. A. Araoz
The Year in Cardiac Imaging
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 542 - 551.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.